Instituto Americas - COI
Instituto Americas - COI
Americas Medical City, Av. Jorge Curi, 550 - Bloco A, Sala 347 - Barra da Tijuca, Rio de Janeiro - RJ, 22775-001
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Fernando Monteiro
Angelo Maiolino
Raphaela Lima
Juliana Pecoraro
Ully Costa
Juliana Oliveira
Open studies
Multiple myeloma
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) - EXCALIBER-RRMM - CelgeneSee more
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) - Successor-1 - Bristol-Myers SquibbSee more
A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) - SUCCESSOR-2 - Bristol-Myers SquibbSee more
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma - MajesTEC-9 - Janssen Research & Development, LLCSee more
Lung cancer
A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC) - LIBRETTO-432 - Loxo Oncology, Inc.See more
Skin cancer
A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma - RELATIVITY-127 - Bristol-Myers SquibbSee more
